Goodwin Leader Says Life Sciences Is Overbuilt In Boston
In the first of a series of Q&As looking at life sciences real estate in various U.S. markets, one of Goodwin Procter LLP's real estate leaders told Law360 that, after a COVID-19-related surge,...To view the full article, register now.
Already a subscriber? Click here to view full article